Home › Pathways › Neurological Conditions Clinical Trials
⚡

Neurological Conditions Clinical Trials

Neurological conditions affect over 10 million people in the UK. Clinical trials are at the forefront of developing new treatments — from disease-modifying drugs for Alzheimer's and MS to advanced neurostimulation for epilepsy and migraine. This pathway connects you to trials across all major neurological conditions.

7 Conditions 4 Comparisons

Disease-Modifying Breakthroughs

Recent years have seen landmark results in neurology trials. Lecanemab and donanemab have demonstrated the ability to slow Alzheimer's disease progression by clearing amyloid plaques. BTK inhibitors are being tested for MS with promising results. For Parkinson's, trials targeting alpha-synuclein are exploring whether the disease process itself can be modified rather than just managing symptoms.

Neurostimulation and Device Trials

Device-based treatments are a growing area of neurological research. Vagus nerve stimulation (VNS) for epilepsy and treatment-resistant depression, deep brain stimulation (DBS) for Parkinson's and essential tremor, and transcranial magnetic stimulation for migraine are all active trial areas. These trials often suit patients who have not responded to medication alone.

Stroke Recovery and Rehabilitation Trials

Stroke trials in the UK focus on both acute treatment (thrombectomy, clot-busting drugs) and rehabilitation (robotic therapy, brain-computer interfaces, virtual reality training). The NHS stroke trials network is one of the most active in Europe, with centres in London, Manchester, Glasgow, and Birmingham.

📋 Conditions

⚖️ Comparisons

📰 Related Articles

Frequently Asked Questions

What are disease-modifying treatments in neurology?
Disease-modifying treatments (DMTs) aim to slow or halt the underlying progression of a neurological condition, rather than just managing symptoms. In MS, several DMTs are already available. In Alzheimer's, new drugs like lecanemab represent the first disease-modifying options, currently being evaluated in ongoing trials.
Can I join a neurology trial if I was recently diagnosed?
Yes. Many trials specifically seek newly diagnosed patients who have not yet started treatment, as this provides the clearest picture of a drug's effects. Your neurologist can help identify trials appropriate for your stage of diagnosis.

Find Your Clinical Trial

Search thousands of actively recruiting trials across the UK — free, instant, no registration.

Search Trials Now Read the Guide